Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
42.6M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
26.4M
-
Shares change
-
+479K
-
Total reported value, excl. options
-
$824M
-
Value change
-
+$15.2M
-
Put/Call ratio
-
0.52
-
Number of buys
-
25
-
Number of sells
-
-32
-
Price
-
$31.18
Significant Holders of Repare Therapeutics Inc. - Common Shares, no par value (RPTX) as of Q2 2021
76 filings reported holding RPTX - Repare Therapeutics Inc. - Common Shares, no par value as of Q2 2021.
Repare Therapeutics Inc. - Common Shares, no par value (RPTX) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.4M shares
of 42.6M outstanding shares and own 62.06% of the company stock.
Largest 10 shareholders include BVF INC/IL (3.72M shares), ORBIMED ADVISORS LLC (3.43M shares), FMR LLC (2.78M shares), Redmile Group, LLC (2.62M shares), CHI Advisors LLC (2.54M shares), MPM ASSET MANAGEMENT LLC (2.27M shares), ARK Investment Management LLC (2.03M shares), MPM Oncology Impact Management LP (1.68M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.18M shares), and Artal Group S.A. (550K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.